These include: NIST SRM 1949 (Frozen Human Prenatal Serum), NIST Candidate RM 8231 (Frozen Human Plasma Suite for Metabolomics), NIST Candidate RM 8232 (Frozen Human Urine Suite for Metabolomics), and NIST Candidate RM 8462 (Frozen Human Liver Suite for Omics; "candidate" refers to materials near the end of the development cycle that are likely available soon, but not as of April 2024). We see QC4 suites as an opportunity for future development, which may include demonstration of proteomics fit for purpose in existing suites or creation and distribution of new suites.